Status:
COMPLETED
Benefits of Exercise Program in Pediatric HSCT
Lead Sponsor:
Phoenix Children's Hospital
Conditions:
Exercise
Transplantation
Eligibility:
All Genders
4-21 years
Phase:
NA
Brief Summary
Deconditioning is a common adverse effect of short and long-term immobilization. For months pediatric hematopoietic stem cell transplant patients can be quarantined while hospitalized, much of which t...
Detailed Description
Despite growing numbers of publications describing the effects of these exercise modalities in adult HSCT patients, only limited attention has been paid to this effective supportive therapy in childre...
Eligibility Criteria
Inclusion
- Subjects age 4-21 years
- Admitted for Hematopoietic Stem Cell Transplant
Exclusion
- Patients with any preexisting need for gait assistance such as crutches, wheelchair, braces, or walker
- Previous Stem Cell Transplant in the last 6 months
- Patients with grade 3 or greater sensory/motor neuropathy
Key Trial Info
Start Date :
March 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04663503
Start Date
March 11 2019
End Date
April 12 2021
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix Children's Hospital
Phoenix, Arizona, United States, 85016